FDA updates labeling for OLANZAPINE FDA Approval Dec. 05, 2025, 12:44 UTC Labeling changes approved for TORRENT. Active ingredient: OLANZAPINE. Decision date: 12/03/2025 Full text
There are no comments here yet...